|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Inventory, net | ||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||
| Licensed technology, net | ||||||||||||||||||
| Right-of-use assets, operating lease | ||||||||||||||||||
| Licensed technology | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Non-current assets of discontinued operations | ||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||
| LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued expenses | ||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Convertible note payable, net | ||||||||||||||||||
| Derivative liability | ||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||
| Non-current liabilities of discontinued operations | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Temporary equity | ||||||||||||||||||
| Temporary equity | ||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 403 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively. | ||||||||||||||||||
| Common stock, $0.0001 par value, 200,000,000 shares authorized; 4,151,919 and 2,525,778 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively. | ||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total Stockholders’ equity | ||||||||||||||||||
| TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY |
Loading...
